Drugs / Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06132789 | Nov 2023 → Aug 2024 | rabies | Ab&B Bio-tech Co., Ltd.JS | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07275645 Comparator | Feb → Apr 2026 overdue | rabies | Ab&B Bio-tech Co., Ltd.JS | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06132789 ↗ |
| Modality | Vaccine | “This vaccine（1.0ml） is produced by Ab\&b Biotechnology Co., Ltd.JS.” NCT06132789 ↗ |
| Route | Intramuscular | “vaccinated by intramuscular injection” NCT06132789 ↗ |